Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment

References

• Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR–5):1–30. quiz CE2-4.
   PubMedGoogle Scholar
• Tseng HF, Bruxvoort K, Ackerson B, et al. The epidemiology of herpes zoster in immunocompetent, unvaccinated adults ≥50 years old: incidence, complications, hospitalization, mortality, and recurrence. J Infect Dis. 2020;222(5):798–806.
   PubMed Web of Science ®Google Scholar
• John AR, Canaday DH. Herpes zoster in the older adult. Infect Dis Clin North Am. 2017;31(4):811–826.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc. 2017;92(12):1806–1821.
   PubMed Web of Science ®Google Scholar
• Ozawa S, Portnoy A, Getaneh H, et al. Modeling the economic burden of adult vaccine-preventable diseases in the United States. Health Aff (Millwood). 2016;35(11):2124–2132.
   PubMed Web of Science ®Google Scholar
• McLaughlin JM, McGinnis JJ, Tan L, et al. Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013. J Prim Prev. 2015;36(4):259–273.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89(25):265–287.
   PubMedGoogle Scholar
• Meyers JL, Madhwani S, Rausch D, et al. Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States. Hum Vaccin Immunother. 2017;13(8):1861–1872.
   PubMed Web of Science ®Google Scholar
• Merck [Internet]. Kenilworth (NJ): Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.; c2009–2020. Zostavax [package insert]. Zoster Vaccine Live. Full Prescribing Information; 2019 Sep [cited 2019 Aug 1]. Available from: https://www.merck.com/product/usa/pi_circulars/z/zostavax/zostavax_pi2.pdf.
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): Centers for Disease Control and Prevention. Shingles (Herpes Zoster). Vaccination; 2019 Jul 1 [cited 2021 Jan 25]. Available from: https://www.cdc.gov/shingles/vaccination.html.
   Google Scholar
• U.S. Food & Drug Administration [Internet]. White Oak (MD): U.S. Food & Drug Administration. Shingrix [package insert]. Zoster Vaccine Recombinant, Adjuvanted. Full Prescribing Information; 2019 May 17 [cited 2019 Aug 1]. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM581605.pdf.
   Google Scholar
• Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67(3): 103–108.
   PubMed Web of Science ®Google Scholar
• Lu PJ, Euler GL, Harpaz R. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Am J Prev Med. 2011;40(2):e1–e6.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): Centers for Disease Control and Prevention. Vaccination Coverage among Adults in the United States, National Health Interview Survey, 2017; 2018 Feb 8 [cited 2019 Aug 1]. Available from: https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/NHIS-2017.html.
   Google Scholar
• Wingate LT, Stubbs K, Ahmed I, et al. The economic impact of herpes zoster vaccine disparities in elderly United States blacks. Int J Environ Res Public Health. 2018;15(10): 2128.
   Web of Science ®Google Scholar
• Eilers R, De Melker HE, Veldwijk J, et al. Vaccine preferences and acceptance of older adults. Vaccine. 2017;35(21):2823–2830.
   PubMed Web of Science ®Google Scholar
• Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4): 403–413.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): Centers for Disease Control and Prevention. Vaccination Coverage Among Adults in the United States, National Health Interview Survey, 2016; 2018 Feb 8 [cited 2019 Aug 1]. Available from: https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/NHIS-2016.html.
   Google Scholar
• Gabutti G, Valente N, Sulcaj N, et al. Evaluation of efficacy and effectiveness of live attenuated zoster vaccine. J Prev Med Hyg. 2014;55(4):130–136.
   PubMedGoogle Scholar
• Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–2096.
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019–1032.
   PubMed Web of Science ®Google Scholar
• Dey A. Orthogonal fractional factorial designs. New York (NY): Halstead Press; 1985.
   Google Scholar
• Huber J, Zwerina K. The importance of utility balance in efficient choice designs. J Mark Res. 1996;33(3):307–317.
   Web of Science ®Google Scholar
• Kanninen BJ. Optimal design for multinomial choice experiments. J Market Res. 2002;39(2):214–227.
   Web of Science ®Google Scholar
• Kuhfeld WF, Tobias RD, Garratt M. Efficient experimental design with marketing research applications. J Mark Res. 1994;31(4):545–557.
   Web of Science ®Google Scholar
• Marshall D, Bridges JF, Hauber B, et al. Conjoint analysis applications in health - how are studies being designed and reported?: an update on current practice in the published literature between 2005 and 2008. Patient. 2010;3(4):249–256.
   PubMedGoogle Scholar
• Greene WH, Hensher DA. A latent class model for discrete choice analysis: contrasts with mixed logit. Transp Res Part B. 2003;37(8):681–698.
   Web of Science ®Google Scholar
• Guo N, Zhang G, Zhu D, et al. The effects of convenience and quality on the demand for vaccination: results from a discrete choice experiment. Vaccine. 2017;35(21): 2848–2854.
   PubMed Web of Science ®Google Scholar
• De Bekker-grob EW, Veldwijk J, Jonker M, et al. The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: a discrete choice experiment. Vaccine. 2018;36(11):1467–1476.
   PubMed Web of Science ®Google Scholar
• Verelst F, Kessels R, Delva W, et al. Drivers of vaccine decision-making in South Africa: a discrete choice experiment. Vaccine. 2019;37(15):2079–2089.
   PubMed Web of Science ®Google Scholar
• Lavelle TA, Messonnier M, Stokley S, et al. Use of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States. J Patient Rep Outcomes. 2019;3(1):51.
   PubMedGoogle Scholar
• Marshall HS, Chen G, Clarke M, et al. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a discrete choice experiment. Vaccine. 2016;34(5):671–677.
   PubMed Web of Science ®Google Scholar
• Poulos C, Curran D, Anastassopoulou A, et al. German travelers’ preferences for travel vaccines assessed by a discrete choice experiment. Vaccine. 2018;36(7): 969–978.
   PubMed Web of Science ®Google Scholar
• Poulos C, Standaert B, Sloesen B, et al. Preferences for vaccines against children’s diarrheal illness among mothers in Poland and Hungary. Vaccine. 2018;36(40): 6022–6029.
   PubMed Web of Science ®Google Scholar
• Poulos C, Yang JC, Levin C, et al. Mothers’ preferences and willingness to pay for HPV vaccines in Vinh long province, Vietnam. Soc Sci Med. 2011;73(2):226–234.
   PubMed Web of Science ®Google Scholar
• Brown DS, Johnson FR, Poulos C, et al. Mothers’ preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine. 2010;28(7):1702–1708.
   PubMed Web of Science ®Google Scholar
• American College of Physicians [Internet]. Philadelphia (PA): American College of Physicians; c2019. Addressing the Increasing Burden of Health Insurance Cost Sharing. A Position Paper; 2016 [cited 2019 Aug 1]. Available from: https://www.acponline.org/acp_policy/policies/insurance_cost_sharing_2016.pdf.
   Google Scholar
• Adult Vaccine Access Coalition [Internet]. Washington (DC): Adult Vaccine Access Coalition; c2015–2020. Medicare Financial Barriers Fact Sheet. Financial Barriers to Adult Immunization. 2017 Mar [cited 2019 Aug 1]. Available from: https://www.adultvaccinesnow.org/wp-content/uploads/2017/03/avac_financial_barriers_FINAL_.pdf.
   Google Scholar
• Yan S, DerSarkissian M, Bhak RH, et al. Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis. Curr Med Res Opin. 2018;34(7):1261–1269.
   PubMed Web of Science ®Google Scholar
• Akinbosoye OE, Taitel MS, Grana J, et al. Factors associated with Zostavax abandonment. Am J Pharm Benefits. 2016;8(4):84–89.
   Web of Science ®Google Scholar
• Lipton BJ, Decker SL. ACA provisions associated with increase in percentage of young adult women initiating and completing the HPV vaccine. Health Aff (Millwood). 2015;34(5):757–764.
   PubMed Web of Science ®Google Scholar
• Ventola CL. Immunization in the United States: recommendations, barriers, and measures to improve compliance: part 2: adult vaccinations. P T. 2016;41(8):492–506.
   PubMedGoogle Scholar
• Reed Johnson F, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13.
   PubMed Web of Science ®Google Scholar
• Hauber AB, González JM, Groothuis-Oudshoorn CG, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016;19(4):300–315.
   PubMed Web of Science ®Google Scholar